The Antibacterial Activity of Crude Extracts of Secondary Metabolites from Bacterial Endophytes Associated with Dicoma anomala

Table 3

Minimum inhibitory concentrations of crude extracts of secondary metabolites from bacterial endophytes associated with Dicoma anomala.

	Pathogenic test strains
	E. coli (ATCC25922)	B. cereus (ATCC10876)	S. aureus (NCTC6571)	P. aeruginosa (ATCC27853)	K. oxytoca (ATCC13182)
Bacterial Endophyte’s crude extracts	MIC (mg/mL)
Stenotrophomonas sp. strain MHSD20	2.5	0.625	2.5	1.25	5
Enterobacter sp. strain MHSD22	2.5	5	2.5	5	10
Staphylococcus sp. strain MHSD26	5	0.625	0.312	2.5	10
Bacillus sp. strain MHSD28	0.625	2.5	0.312	2.5	2.5
Stenotrophomonas sp. strain MHSD12	1.25	0.625	2.5	0.625	5
Bacillus sp. strain MHSD14	5	0.312	1.25	5	2.5
Pantoea sp. strain MHSD15	1.25	2.5	0.625	2.5	10

Streptomycin (positive control) inhibited all the test strains at 1 mg/mL.